Compare Flagstar Bank NA (FLG) vs Johnson & Johnson (JNJ) Price & Performance

Flagstar Bank (FLG) trades at $11.32, showing modest daily gains of 0.18%. The stock faces bearish technical signals with all moving averages indicating selling pressure, though oscillators are neutral. Fundamentally, the company reported a Q2 2026 earnings miss but maintains profitability with a net income margin of 2.3%. Recent developments include a strategic core banking partnership with Fiserv and a $250 million share repurchase program announced in July 2026.

Analyst consensus remains bullish with a $17.07 price target (60% buy ratings), suggesting significant upside potential. However, risks include recent earnings volatility, high P/E ratio of 378, and negative operating cash flow in 2025. The stock trades below book value (P/B 0.62), offering value opportunity if operational improvements continue.

Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).

JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.